Skip to the page

Data / Form D filings / EnteroTrack, LLC

EnteroTrack, LLC: Form D filings

EnteroTrack, LLC, a biotechnology company in Aurora, CO, filed 3 Form D notices with the SEC between 2014 and 2026. The latest, on September 25, 2026, reports $2 million sold of a $2 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
12675 E. MONTVIEW BOULEVARD SUITE 215LC, Aurora, CO, 80045
Phone
(720) 724-4196
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Colorado
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1612812

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 25, 2026New notice$2,000,000$2,000,0004Sep 15, 2026sec.gov
Jun 4, 2021New notice$4,660,000$4,660,0001May 21, 2021sec.gov
Jul 9, 2014New notice$500,000$250,000$250,0001May 20, 2014sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Robin ShandasExecutive Officer, Director
Glenn T. FurutaDirector
Steven J. AckermanDirector
Jeffrey HarringtonDirector

Other biotechnology companies in Colorado that filed recently

Every Form D from the week of Sep 21, 2026 · All recent filings in Colorado · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what EnteroTrack, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.